Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The intestinal epithelial cell extracellular matrix (ECM) and mucus components constitute a complex, multi-layered structural system essential for maintaining gastrointestinal homeostasis and barrier integrity. The mucus layer, primarily composed of the gel-forming glycoprotein Mucin-2 (MUC2), serves as a physical and chemical shield that protects the underlying epithelium from mechanical stress, digestive enzymes, and commensal or pathogenic microorganisms (Johansson & Hansson, 2016, Nature Reviews Gastroenterology & Hepatology). Beneath the mucus, the ECM provides a scaffold of collagens, laminins, and fibronectin that anchors epithelial cells and regulates critical cellular processes such as proliferation, migration, and differentiation through integrin-mediated signaling (Bonnans et al., 2014, Journal of Cell Science). In pathological states like Inflammatory Bowel Disease (IBD) or colorectal cancer, the composition and organization of these components are often disrupted, leading to increased intestinal permeability and aberrant cell signaling (Turner, 2009, Gastroenterology). While not a single therapeutic target, this system is modulated by mucosal protectants like rebamipide and sucralfate, which aim to reinforce the barrier or protect exposed ECM in ulcerated tissues. Understanding the collective function of these components is vital for developing strategies to treat chronic inflammatory conditions and improve the delivery of oral therapeutics.
Stimulation of mucin synthesis, stabilization of the glycoprotein matrix, and physical coating of exposed extracellular matrix proteins to prevent enzymatic degradation and pathogen adherence.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Intestinal epithelial cell extracellular matrix and mucus components (IEC-ECM/Mucus).